GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ModivCare Inc (NAS:MODV) » Definitions » Gross-Profit-to-Asset %

ModivCare (ModivCare) Gross-Profit-to-Asset % : 26.59% (As of Dec. 2023)


View and export this data going back to 2003. Start your Free Trial

What is ModivCare Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. ModivCare's annualized Gross Profit for the quarter that ended in Dec. 2023 was $469 Mil. ModivCare's average Total Assets over the quarter that ended in Dec. 2023 was $1,765 Mil. Therefore, ModivCare's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 26.59%.


ModivCare Gross-Profit-to-Asset % Historical Data

The historical data trend for ModivCare's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ModivCare Gross-Profit-to-Asset % Chart

ModivCare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.64 28.65 23.90 23.78 24.08

ModivCare Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.39 23.07 23.58 24.29 26.59

Competitive Comparison of ModivCare's Gross-Profit-to-Asset %

For the Medical Care Facilities subindustry, ModivCare's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ModivCare's Gross-Profit-to-Asset % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, ModivCare's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where ModivCare's Gross-Profit-to-Asset % falls into.



ModivCare Gross-Profit-to-Asset % Calculation

ModivCare's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=446.952/( (1944.272+1767.275)/ 2 )
=446.952/1855.7735
=24.08 %

ModivCare's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=469.396/( (1763.086+1767.275)/ 2 )
=469.396/1765.1805
=26.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


ModivCare Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of ModivCare's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


ModivCare (ModivCare) Business Description

Traded in Other Exchanges
Address
6900 Layton Avenue, 12th Floor, Denver, CO, USA, 80237
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. The company is also a provider of non-emergency medical transportation, or NEMT, personal care, and remote patient monitoring, or RPM, solutions, which serve similar, highly vulnerable patient populations. Its operating segment includes NEMT, Personal Care, and Remote Patient Monitoring. The company generates maximum revenue from the NEMT segment.
Executives
Barbara Gutierrez officer: Chief Financial Officer 8950 E. LOWRY BLVD., DENVER CO 80230
L Heath Sampson officer: Chief Financial Officer C/O ADVANCED EMISSIONS SOLUTIONS, INC., 9135 S RIDGELINE BLVD STE 200, HIGHLANDS RANCH CO 80129
Coliseum Capital Management, Llc director, 10 percent owner 105 ROWAYTON AVENUE, ROWAYTON CT 06853
Henry Toledo officer: Chief People Officer 6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Jessica Kral officer: Chief Information Officer 6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Anne E, Bailey officer: President, Home Division 6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Rebecca Orcutt officer: VP, Chief Accounting Officer 6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Brett M. Hickman officer: Chief Commercial Officer 6900 LAYTON AVENUE, SUITE 1200, DENVER CO 80237
Ilias Simpson officer: President, Transportation 6900 LAYTON AVENUE, SUITE 1200, DENVER CO 80237
Jason E Anderson officer: President of ModivCare Home 6900 LAYTON AVENUE, SUITE 1200, DENVER CO 80237
Grover Wray officer: Chief Human Resources Officer DIGITALGLOBE, INC., 1300 WEST 120TH AVENUE, WESTMINSTER CO 80234
Daniel E Greenleaf director, officer: CEO and President C/O NABI BIO PHARMACEUTICALS, 5800 PARK OF COMMERCE BLVD., N.W., BOCA RATON FL 33487
Jonathan B Bush officer: SVP, GC and Secretary 6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Kenneth Shepard officer: Vice President, CAO 6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Stacy Saal director 4700 SOUTH SYRACUSE STREET, 4TH FLOOR, DENVER CO 80237